| [1] |
Qin Meijie, Tian Maolu, Yang Yuqi, Zha Yan, Yuan Jing.
Literature review on treatment of immune thrombocytopenia secondary to refractory systemic lupus erythematosus with belimumab combined with cyclosporine: A case report and literature review
[J]. Clinical Focus, 2022, 37(6): 544-547.
|
| [2] |
Gao Yuan;Meng Qinghua;Liu Haixia;Zhu Yueke.
Abnormal liver function as the first symptom of systemic lupus erythematosus: analysis of 15 cases
[J]. Clinical Focus, 2015, 30(7): 806-810.
|
| [3] |
HUANG Zhi-fang;LI Xin-lun;LI Hong-xia;LUN Li-de.
Efficacy and safety of intravenous immunoglobulin in severe systemic lupus erythematosus
[J]. Clinical Focus, 2014, 29(11): 1243-1245.
|
| [4] |
.
[J]. Clinical Focus, 2014, 29(9): 1066-1067.
|
| [5] |
LI Hong-bo;ZHANG Jing-kun;WU Chao;WANG Ji;ZHANG Yu-jun;GAO Li-xia.
Relationship of high mobility group protein 1,Toll-like receptors 4, vascular endothelial cell adhesion molecule-1 expression in lupus nephritis with dyslipidemia
[J]. Clinical Focus, 2014, 29(8): 891-895.
|
| [6] |
.
[J]. CLINICAL FOCUS, 2013, 28(10): 1179-1181.
|
| [7] |
WANG Zeng-ling;XING Guang-qun;LI Chun-mei.
Level and significance of serum peptidylarginine deiminase type 4 in patients with systemic lupus erythematous
[J]. Clinical Focus, 2013, 28(5): 515-518.
|
| [8] |
XU Xiao-ling;YU Xuan-hua;LI Yi-nong.
Levels and clinical significance of B cell activating factor and interferon-α in systemic lupus erythematosus
[J]. Clinical Focus, 2013, 28(5): 522-524532.
|
| [9] |
.
[J]. Clinical Focus, 2012, 27(19): 1741-1742.
|
| [10] |
.
[J]. Clinical Focus, 2012, 27(6): 527-528.
|
| [11] |
.
[J]. CLINICAL FOCUS, 2011, 26(5): 435-436.
|
| [12] |
YU Xuan-hua;LI Yi-nong.
Clinical cardiac imaging characteristics and influencing factors in 85 cases patients with systemic lupus erythematosus
[J]. CLINICAL FOCUS, 2010, 25(13): 1119-1122.
|
| [13] |
.
[J]. CLINICAL FOCUS, 2010, 25(13): 1175-0.
|
| [14] |
.
[J]. CLINICAL FOCUS, 2010, 25(8): 699-701.
|
| [15] |
.
[J]. CLINICAL FOCUS, 2009, 24(16): 1442-1443.
|
